Learn how genetic healthcare services have adapted to virtual care delivery, and what challenges face its widespread use after the COVID-19 pandemic is over.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Since the onset of the COVID-19 pandemic, telehealth has become a much wider practice, enabling millions to receive care at home. Genetic screening, testing, and counseling are particularly amenable to telehealth, but their future remains to be seen. On this episode of CANCER BUZZ, we look at how genetic healthcare services have adapted to virtual delivery, and what challenges face its widespread use after the pandemic is over.
Guest: Feyi Olopade Ayodele, MBA, Chief Executive Officer, CancerIQ, Inc.
Related Content:
March 5, 2026
February 19, 2026
January 30, 2026
January 21, 2026
